Literature DB >> 10201892

Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction.

J A Losman1, X P Chen, D Hilton, P Rothman.   

Abstract

IL-4 is an important regulator of the activation, proliferation, and differentiation of many hematopoetic cells. Many of these biological effects result from the activation of Janus kinases (JAK)1 and JAK3 and the transcription factor Stat6. Recent data suggest that members of the SOCS (suppressor of cytokine signaling) family of proteins can inhibit JAK-STAT signaling. We have examined the ability of SOCS family members to suppress IL-4 signaling, and we have found that SOCS-1 potently inhibits the activation of JAK1 kinase and Stat6 in response to IL-4. Furthermore, SOCS-1 can inhibit the induction of CD23 expression by IL-4. SOCS-2 does not inhibit induction of signaling by IL-4, while inhibition of IL-4 signaling by SOCS-3 can be detected in transient transfection systems, but not in stable cell lines. These studies implicate SOCS-1 in modulation of IL-4 signaling and suggest that SOCS-1 may play a role in regulating the immune response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201892      PMCID: PMC3836448     

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  DEAE-dextran enhances electroporation of mammalian cells.

Authors:  G H Gauss; M R Lieber
Journal:  Nucleic Acids Res       Date:  1992-12-25       Impact factor: 16.971

2.  Jak1 expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat6 signaling molecules.

Authors:  X H Chen; B K Patel; L M Wang; M Frankel; N Ellmore; R A Flavell; W J LaRochelle; J H Pierce
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

3.  The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4-specific gene expression.

Authors:  M Reichel; B H Nelson; P D Greenberg; P B Rothman
Journal:  J Immunol       Date:  1997-06-15       Impact factor: 5.422

4.  Stat6 is required for mediating responses to IL-4 and for development of Th2 cells.

Authors:  M H Kaplan; U Schindler; S T Smiley; M J Grusby
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

5.  IL-4 activates a latent DNA-binding factor that binds a shared IFN-gamma and IL-4 response element present in the germ-line gamma 1 Ig promoter.

Authors:  M T Berton; L A Linehan
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

6.  Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3.

Authors:  Z Wen; J E Darnell
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

Review 7.  Interleukin-4 receptor signalling mechanisms and their biological significance.

Authors:  K Nelms; H Huang; J Ryan; A Keegan; W E Paul
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

8.  Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene.

Authors:  K Shimoda; J van Deursen; M Y Sangster; S R Sarawar; R T Carson; R A Tripp; C Chu; F W Quelle; T Nosaka; D A Vignali; P C Doherty; G Grosveld; W E Paul; J N Ihle
Journal:  Nature       Date:  1996-04-18       Impact factor: 49.962

9.  Essential role of Stat6 in IL-4 signalling.

Authors:  K Takeda; T Tanaka; W Shi; M Matsumoto; M Minami; S Kashiwamura; K Nakanishi; N Yoshida; T Kishimoto; S Akira
Journal:  Nature       Date:  1996-04-18       Impact factor: 49.962

10.  Jak-STAT signaling induced by the v-abl oncogene.

Authors:  N N Danial; A Pernis; P B Rothman
Journal:  Science       Date:  1995-09-29       Impact factor: 47.728

View more
  38 in total

1.  SOCS-1 localizes to the microtubule organizing complex-associated 20S proteasome.

Authors:  Bao Q Vuong; Teresita L Arenzana; Brian M Showalter; Julie Losman; X Peter Chen; Justin Mostecki; Alexander S Banks; Andre Limnander; Neil Fernandez; Paul B Rothman
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

Review 2.  Regulation of CD4+ T-cell polarization by suppressor of cytokine signalling proteins.

Authors:  Camille A Knosp; James A Johnston
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

3.  Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease.

Authors:  J Morgan Knight; Pijus Mandal; Pietro Morlacchi; Garbo Mak; Evan Li; Matthew Madison; Cameron Landers; Brandon Saxton; Ed Felix; Brian Gilbert; Joel Sederstrom; Atul Varadhachary; Melissa M Singh; Dev Chatterjee; David B Corry; John S McMurray
Journal:  J Biol Chem       Date:  2018-05-08       Impact factor: 5.157

Review 4.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

5.  Inhibition of MicroRNA-221 Alleviates Neuropathic Pain Through Targeting Suppressor of Cytokine Signaling 1.

Authors:  Li Xia; Yunlong Zhang; Tieli Dong
Journal:  J Mol Neurosci       Date:  2016-04-08       Impact factor: 3.444

6.  Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis.

Authors:  Norihiko Takeda; Ellen L O'Dea; Andrew Doedens; Jung-whan Kim; Alexander Weidemann; Christian Stockmann; Masataka Asagiri; M Celeste Simon; Alexander Hoffmann; Randall S Johnson
Journal:  Genes Dev       Date:  2010-03-01       Impact factor: 11.361

7.  No association between the SOCS-1 -1478CA/del polymorphism and ulcerative colitis in Turkish subjects.

Authors:  Mustafa Hartavi; Selim Giray Nak; Barbaros Oral; Adem Deligönül
Journal:  Mol Biol Rep       Date:  2014-07-02       Impact factor: 2.316

Review 8.  SOCS1 and its Potential Clinical Role in Tumor.

Authors:  Jie Ying; Xiaoyan Qiu; Yu Lu; Miaomiao Zhang
Journal:  Pathol Oncol Res       Date:  2019-02-13       Impact factor: 3.201

9.  Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation.

Authors:  Yoh-Ichi Seki; Katsuhiko Hayashi; Akira Matsumoto; Noriyasu Seki; Jun Tsukada; John Ransom; Tetsuji Naka; Tadamitsu Kishimoto; Akihiko Yoshimura; Masato Kubo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

Review 10.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.

Authors:  Xiaoyu Hu; Lionel B Ivashkiv
Journal:  Immunity       Date:  2009-10-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.